These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5871082)

  • 1. Immunological studies on shigellosis by the mouse model technique. I. Antiinfective immunity of actively immunized mice.
    Rauss K; Kétyi I
    Acta Microbiol Acad Sci Hung; 1965-1966; 12(4):377-86. PubMed ID: 5871082
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological studies on shigellosis by the mouse model technique. I. Antiinfective immunity of actively immunized mice.
    Rauss K; K0etyi I
    Acta Microbiol Acad Sci Hung; 1965-1966; 12(4):377-86. PubMed ID: 5871033
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological studies on shigellosis by the mouse model technique. II. Antiinfective immunity of passively immunized mice.
    Rauss K; Kétyi I
    Acta Microbiol Acad Sci Hung; 1965-1966; 12(4):387-93. PubMed ID: 5870705
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
    DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
    J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
    DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
    J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
    [No Abstract]   [Full Text] [Related]  

  • 6. Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development.
    Sansonetti P; Phalipon A
    Res Immunol; 1996; 147(8-9):595-602. PubMed ID: 9127893
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to experimental mouse shigellosis.
    Rauss K; Kétyi I
    Arch Immunol Ther Exp (Warsz); 1968; 16(3):491-6. PubMed ID: 5666686
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental model of keratoconjunctival infections in the study of immunity against Shigella].
    Cefalù M; Puglisi C
    G Mal Infett Parassit; 1972 Apr; 24(4):281-9. PubMed ID: 5050309
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on acquired systemic resistance in mice with oral immunization with Shigella sonnei.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):345-55. PubMed ID: 7004395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stimulation of antidysentery immunity with acetoxan].
    Gorbunova ES
    Antibiotiki; 1966 Apr; 11(4):354-8. PubMed ID: 4861976
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on experimental shigellosis: relationship between the proliferation of Shigella bacilli in the intestine and the intestinal flora in mice].
    Takeuchi K
    Nihon Densenbyo Gakkai Zasshi; 1969 Feb; 42(11):299-306. PubMed ID: 4977192
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacteriological and epidemiological approaches to the prophylaxis of enteric infection. VI. In vitro studies on the mechanism of acquired resistance to Shigella flexneri infection (1).
    Sakaguchi T; Sakaguchi S; Okamoto M; Matsui S; Anzai H
    Kitasato Arch Exp Med; 1980 Dec; 53(3-4):97-109. PubMed ID: 7035741
    [No Abstract]   [Full Text] [Related]  

  • 14. Adoptive transfer of immunity to dysentery bacilli with immune T lymphocytes from mice orally immunized with Shigella sonnei bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):593-601. PubMed ID: 7006564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide.
    Cohen D; Green MS; Block C; Slepon R; Lerman Y
    J Infect Dis; 1992 Apr; 165(4):785-7. PubMed ID: 1552217
    [No Abstract]   [Full Text] [Related]  

  • 16. NAIP-NLRC4-deficient mice are susceptible to shigellosis.
    Mitchell PS; Roncaioli JL; Turcotte EA; Goers L; Chavez RA; Lee AY; Lesser CF; Rauch I; Vance RE
    Elife; 2020 Oct; 9():. PubMed ID: 33074100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal lymphoid infiltrate dominates colonic pathological changes in murine experimental shigellosis.
    Martino MC; Rossi G; Martini I; Tattoli I; Chiavolini D; Phalipon A; Sansonetti PJ; Bernardini ML
    J Infect Dis; 2005 Jul; 192(1):136-48. PubMed ID: 15942903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An experimental study of postvaccination and postinfectious immunity to dysenteria in guinea-pigs.
    Manolov DG; Kosturkov GB
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):347-52. PubMed ID: 5629951
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulant effect of yeast on antibody production, resistance and plasmoblastic reaction in animals.
    Zemskov MV; Ignat'eva SA; Morozova VP; Stepanov II; Zhuravleva NV
    Fed Proc Transl Suppl; 1966; 25(1):139-40. PubMed ID: 5215787
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serodiagnosis of dysentery using Shigella diagnostic agents (synthetic colored and erythrocytic)].
    Nikitin VM; Sichinskiĭ LA
    Lab Delo; 1985; (7):432-4. PubMed ID: 2414530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.